King's College London

Research portal

Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective

Research output: Contribution to journalArticle

Anja Ten Brinke, Marc Martinez-Llordella, Nathalie Cools, Catharien M.U. Hilkens, S. Marieke van Ham, Birgit Sawitzki, Edward K. Geissler, Giovanna Lombardi, Piotr Trzonkowski, Eva Martinez-Caceres

Original languageEnglish
Article number181
Pages (from-to)181
Number of pages1
JournalFrontiers in Immunology
Issue numberFEB
Publication statusPublished - 22 Feb 2019

King's Authors


Clinical studies with cellular therapies using tolerance-inducing cells, such as tolerogenic antigen-presenting cells (tolAPC) and regulatory T cells (Treg) for the prevention of transplant rejection and the treatment of autoimmune diseases have been expanding the last decade. In this perspective, we will summarize the current perspectives of the clinical application of both tolAPC and Treg, and will address future directions and the importance of immunomonitoring in clinical studies that will result in progress in the field.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454